Market Announcements

Change in substantial holding

Download   Fill 1 Copy

Expands Global Footprint with Strategic Partnership in India

Download   Fill 1 Copy

Confirmation of Release – RNV – Response to ASX Aware Letter

Download   Fill 1 Copy

Confirmation of Release – RNV – Clinical Outcome Demonstrates Material Benefits for Patients

Download   Fill 1 Copy

Confirmation of Release – RNV – Notification of cessation of securities – RNV

Download   Fill 1 Copy

Confirmation of Release – RNV – Change of Director's Interest Notice – J Chick

Download   Fill 1 Copy

Cleansing Notice

Download   Fill 1 Copy

ReNerve Limited – Application for quotation of securities

Download   Fill 1 Copy

ReNerve Limited – Proposed issue of securities

Download   Fill 1 Copy

ReNerve Limited Asian Market Update – NervAlign® Nerve Cuff

Download   Fill 1 Copy

ReNerve Receives Additional $139,537 in R&D Tax Incentive Refund

Download   Fill 1 Copy

ReNerve Limited Appendix 4D Half-year report

Download   Fill 1 Copy

ReNerve releases 31 December 2024 Half Year Results

Download   Fill 1 Copy

ReNerve enters partnership for NervAlign® Nerve Cuff in Mexico

Download   Fill 1 Copy

Quarterly Investor Presentation

Download   Fill 1 Copy

Q2 FY25 Activities Report – 29 January 2025

Download   Fill 1 Copy

Announcement – Commencement of Trade as ReNerve Limited – 26 November 2024

Download   Fill 1 Copy

Announcement – ReNerve VivaZome Collaboration – 25 May 2021

Download   Fill 1 Copy

Announcement – FDA Application Update – 15 February 2021

Download   Fill 1 Copy

Announcement – Capital Raising – 5 January 2021

Download   Fill 1 Copy